NCT06300073

Brief Summary

The objective of this single-use, examiner blinded, randomized, two-period, cross-over, IRB-approved clinical study is to evaluate the safety and plaque removal efficacy of AutoBrush®, a new children's 360° sonic toothbrush, compared to a marketed children's manual toothbrush.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2023

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 29, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
Last Updated

March 8, 2024

Status Verified

March 1, 2024

Enrollment Period

3 days

First QC Date

February 29, 2024

Last Update Submit

March 5, 2024

Conditions

Keywords

gingivitistoothbrush

Outcome Measures

Primary Outcomes (1)

  • Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque removal Mean Change from baseline (pre-brushing to post-brushing) in plaque score after single supervised use based on all tooth surfaces of the whole mouth.

    Supragingival dental plaque: Lobene-Soparkar Modification of Turesky Modification of Quigley-Hein Plaque Index Plaque will be disclosed using a red disclosing solution and each tooth will be scored in six areas (disto-buccal, mid-buccal and mesio-buccal, disto-lingual, mid-lingual and mesio-lingual), according to the criteria noted below: 0 = No plaque. 1. = Separate flecks or discontinuous band of plaque at the gingival (cervical) margin. 2. = Thin (up to 1 mm), continuous band of plaque at the gingival margin. 3. = Band of plaque wider than 1 mm but less than 1/3 of tooth surface area. 4. = Plaque covering 1/3 or more, but less than 2/3 of tooth surface area. 5. = Plaque covering 2/3 or more of tooth surface area.

    Up to 2 weeks

Study Arms (2)

AutoBrush U-shaped power toothbrush, then Manual Toothbrush

EXPERIMENTAL

Participants first received the AutoBrush U-shaped power toothbrush with fluoride toothpaste for a single brushing use for 30 seconds; after a 2-day washout period, participants received the ADA reference manual toothbrush for a single brushing use for 2 minutes.

Device: Experimental: U-shaped Power ToothbrushDevice: Placebo Comparator: Soft Manual Toothbrush

Manual Toothbrush

EXPERIMENTAL

Participants first received the ADA reference manual toothbrush for a single brushing use for 2 minutes; after a 2-day washout period, participants received the AutoBrush U-shaped power toothbrush with fluoride toothpaste for a single brushing use for 30 seconds.

Device: Experimental: U-shaped Power ToothbrushDevice: Placebo Comparator: Soft Manual Toothbrush

Interventions

Twice daily brushing for 30 seconds with fluoride toothpaste

AutoBrush U-shaped power toothbrush, then Manual ToothbrushManual Toothbrush

Twice daily brushing for 2 minutes with fluoride toothpaste

AutoBrush U-shaped power toothbrush, then Manual ToothbrushManual Toothbrush

Eligibility Criteria

Age5 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may not qualify if:

  • Subjects presenting with any of the following will not be included in the study:
  • Having a history of adverse effects, oral soft or hard tissue sensitivity, to any ingredient in the test materials.
  • Having self-reported serious medical conditions.
  • Being under treatment for a heart condition requiring use of a pacemaker.
  • Having anything that, in the opinion of the investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study.
  • Having had antibiotic, anti-inflammatory, anti-coagulant medication or chemotherapeutic antiplaque/antigingivitis therapy within 30 days of screening exams.
  • Having participated in any study involving oral care products, concurrently or within the 30 days of screening exams.
  • Presence of severe periodontal disease or being actively treated for periodontal disease.
  • Having grossly carious, fully crowned, or extensively restored teeth.
  • Having orthodontic appliances, peri/oral piercings, or removable partial dentures.
  • Having significant oral soft tissue pathology based on a visual examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salus Research, Inc

Fort Wayne, Indiana, 46825, United States

Location

MeSH Terms

Conditions

Dental PlaqueGingivitis

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic DiseasesInfectionsGingival DiseasesPeriodontal DiseasesMouth Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Examiner and data recorder will not have access to the room for test materials dispensing and instructions.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: single-use, randomized, two-period, cross-over study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 29, 2024

First Posted

March 8, 2024

Study Start

February 14, 2023

Primary Completion

February 17, 2023

Study Completion

February 17, 2023

Last Updated

March 8, 2024

Record last verified: 2024-03

Locations